ReviewJournal of neuroendovascular therapy2026
Flow Diversion in Fetal-Type Posterior Communicating Artery Aneurysms: Anatomical Challenges and Treatment Strategy.
Review in Journal of neuroendovascular therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fetal-type posterior communicating artery (PcomA) aneurysms remain a difficult subgroup in the flow-diverter era. In these lesions, the PcomA supplies a substantial portion of the posterior cerebral artery territory because the ipsilateral P1 segment is absent, hypoplastic, or functionally insufficient. The branch therefore functions as a major outflow channel, and persistent distal demand may maintain circulation through the aneurysm-neck complex after flow diversion. This review summarizes the anatomical basis of fetal-type PcomA aneurysms and the current evidence for clipping, coiling, intrasaccular devices, and flow diversion. Among PcomA aneurysms treated with flow diverters, non-fetal lesions generally show better angiographic outcomes than fetal-type lesions. In a recent meta-analysis, complete occlusion at final follow-up was 77% in non-fetal aneurysms versus 42% in fetal-type aneurysms. A multicenter comparative cohort similarly reported complete occlusion in 81.8% versus 43.7%, with a markedly shorter median time to occlusion in non-fetal lesions (6 vs. 51 months). Earlier fetal-type series often showed persistent aneurysm filling and low complete occlusion rates, whereas more recent selected cohorts have reported complete or near-complete occlusion in 60%-80% of cases, suggesting that flow diversion can still be effective in carefully selected anatomies and with tailored strategies. Overall, clipping and coiling remain important branch-preserving options, and intrasaccular treatment may be reasonable in selected lesions with favorable geometry. Flow diversion should be considered selectively, particularly for large, recurrent, broad-necked, or morphologically complex aneurysms, while recognizing that robust fetal circulation may delay or limit aneurysm occlusion. Current evidence remains constrained by small retrospective series, inconsistent definitions of fetal anatomy, and heterogeneous device strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.